Page 10 - Mark Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: Basel, 22 April 2021 - Roche ((SIX: RO, ROG, OTCQX:RHHBY) and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) at a price of USD 24.05 per share in cash. The tender offer expired at 12:00 midnight, Eastern Time, at the end of the day on 21 April 2021 and was not extended. Roche has been advised by Citibank, N.A., the depositary for the ten...

(0) Vancouver, British Columbia--(Newsfile Corp. - April 21, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today the agreement by several long-time strategic accredited investors and insiders to exercise approximately 2,000,000 warrants issued in connection with the Company's private placement of units completed in April 2019, with the warrant exercise price of $0.20 per share. All the warrants were exercised before the warranty maturity date of April 16, 2021. The gross proceeds to the company from the exercise of the warrants ar...

Extended Stay America, Inc. (NASDAQ: STAY)  WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Extended Stay America, Inc. (NASDAQ: STAY) in connection with the proposed acquisition of the company and its paired-share REIT, ESH Hospitality, Inc., by funds managed by Blackstone Real Estate Partners and Starwood Capital Group. Under the terms of the merger agreement, STAY shareholders will receive $19.50 in cash for each share of STAY common stock that they hold. If you own STAY shares and wish to discuss this investiga...

GenMark Diagnostics, Inc. (NASDAQ: GNMK)  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Roche for $24.05 per share in cash.  If you are a GenMark shareholder, .   Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 o...

)  WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Extended Stay America, Inc. (NASDAQ: STAY) in connection with the proposed acquisition of the company and its paired-share REIT, ESH Hospitality, Inc., by funds managed by Blackstone Real Estate Partners and Starwood Capital Group. Under the terms of the merger agreement, STAY shareholders will receive $19.50 in cash for each share of STAY common stock that they hold. If you own STAY shares and wish to discuss this investigation or your rights, please call us or vi...